StonvexLoading…
StonvexStonvexStonvexCore line items from BLBD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-27 | Annual 2024 2024-09-28 | Annual 2023 2023-09-30 | Annual 2022 2022-10-01 |
|---|---|---|---|---|
Revenue | $1.48B | $1.35B | $1.13B | $800.64M |
Operating Income | $167.17M | $139.33M | $51.66M | $-40.70M |
Net Income | $127.72M | $105.55M | $23.81M | $-45.76M |
EPS (Diluted) | $3.88 | $3.16 | $0.74 | $-1.48 |
Total Assets | $625.25M | $524.89M | $417.77M | $366.13M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $229.31M | $127.69M | $78.99M | $10.48M |
Free Cash Flow OCF − CapEx | $153.34M | $95.85M | $111.41M | $-30.89M |
Shares Outstanding | 31.88M | 32.27M | 32.17M | 32.02M |